131 related articles for article (PubMed ID: 38482546)
21. Risk of Carcinoma in Pleomorphic Adenomas of the Parotid.
Levyn H; Subramanian T; Eagan A; Katabi N; Lin O; Badillo ND; Martinez G; Scholfield DW; Wong RJ; Shah JP; Givi B; Morris LGT; Ganly I; Patel SG
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):1034-1041. PubMed ID: 37824134
[TBL] [Abstract][Full Text] [Related]
22. Aberrant protein expression and promoter methylation of p16 gene are correlated with malignant transformation of salivary pleomorphic adenoma.
Hu YH; Zhang CY; Tian Z; Wang LZ; Li J
Arch Pathol Lab Med; 2011 Jul; 135(7):882-9. PubMed ID: 21732778
[TBL] [Abstract][Full Text] [Related]
23. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
Bahrami A; Dalton JD; Shivakumar B; Krane JF
Head Neck Pathol; 2012 Sep; 6(3):328-35. PubMed ID: 22485045
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for carcinoma ex pleomorphic adenoma in patients presenting with recurrence after resection of pleomorphic adenoma.
Yin LX; Van Abel KM; Rooker SA; Nagelschneider AA; Olsen KD; Price DL; Janus JR; Kasperbauer JL; Moore EJ
Head Neck; 2021 Feb; 43(2):419-427. PubMed ID: 33043539
[TBL] [Abstract][Full Text] [Related]
25. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity and versatility of the extracellular matrix during the transition from pleomorphic adenoma to carcinoma ex pleomorphic adenoma: cumulative findings from basic research and new insights.
Scarini JF; de Lima-Souza RA; Lavareze L; Ribeiro de Assis MCF; Damas II; Altemani A; Egal ESA; Dos Santos JN; Bello IO; Mariano FV
Front Oral Health; 2023; 4():942604. PubMed ID: 37138857
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features.
Asahina M; Saito T; Hayashi T; Fukumura Y; Mitani K; Yao T
Histopathology; 2019 Feb; 74(3):514-525. PubMed ID: 30307055
[TBL] [Abstract][Full Text] [Related]
28. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.
Soares AB; Ponchio L; Juliano PB; de Araújo VC; Altemani A
J Clin Pathol; 2007 Sep; 60(9):995-1000. PubMed ID: 17079351
[TBL] [Abstract][Full Text] [Related]
29. Malignant transformation of salivary gland pleomorphic adenoma: proof of principle.
Valstar MH; Mast H; Ten Hove I; Moonen LR; Balm AJ; Smeele LE; Koljenović S; Dinjens WN; van Velthuysen MF
J Pathol Clin Res; 2021 Sep; 7(5):432-437. PubMed ID: 34390320
[TBL] [Abstract][Full Text] [Related]
30. Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma.
de Souza AA; Altemani A; de Araujo NS; Texeira LN; de Araújo VC; Soares AB
Clin Pathol; 2019; 12():2632010X19873384. PubMed ID: 31598607
[TBL] [Abstract][Full Text] [Related]
31. Promoter hypermethylation may contribute to E‑cadherin repression in the human salivary carcinoma ex pleomorphic adenoma.
Xia L; Hu Y; Gu T; Wang L; Tian Z
Int J Oncol; 2018 Feb; 52(2):496-504. PubMed ID: 29207084
[TBL] [Abstract][Full Text] [Related]
32. Soluble E-cadherin promotes invasiveness of neoplastic cells in salivary gland carcinoma ex pleomorphic adenoma.
Chen W; Ye S; Wang X; Qian J; Xia L; Tian Z
J Oral Pathol Med; 2023 Jan; 52(1):63-71. PubMed ID: 36445289
[TBL] [Abstract][Full Text] [Related]
33. Molecular Factors in Carcinoma Ex Pleomorphic Adenoma: Systematic Review and Meta-Analysis.
Key S; Chia C; Hasan Z; Sundaresan P; Riffat F; Dwivedi RC
Laryngoscope; 2024 Mar; 134(3):1042-1053. PubMed ID: 37610148
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma.
Soares CD; de Lima Morais TM; Carlos R; Martins MD; de Almeida OP; Mariano FV; Altemani A
Hum Pathol; 2019 Oct; 92():59-66. PubMed ID: 31400353
[TBL] [Abstract][Full Text] [Related]
35. Carcinoma ex pleomorphic adenoma of the parotid gland.
Park KS; Kim JH; Lee DH; Lee JK; Lim SC
Am J Otolaryngol; 2022; 43(2):103389. PubMed ID: 35149345
[TBL] [Abstract][Full Text] [Related]
36. Genomic copy number alterations of primary and secondary metastasizing pleomorphic adenomas.
Mariano FV; Gondak Rde O; Martins AS; Coletta RD; Paes de Almeida O; Kowalski LP; Krepischi AC; Altemani A
Histopathology; 2015 Sep; 67(3):410-5. PubMed ID: 25600428
[TBL] [Abstract][Full Text] [Related]
37. Desmoplasia in different degrees of invasion of carcinoma ex-pleomorphic adenoma.
de Araújo VC; Furuse C; Cury PR; Altemani A; Alves VA; de Araújo NS
Head Neck Pathol; 2007 Dec; 1(2):112-7. PubMed ID: 20614261
[TBL] [Abstract][Full Text] [Related]
38. HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study.
Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Nishiyama K; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
Histopathology; 2012 May; 60(6B):E131-42. PubMed ID: 22486195
[TBL] [Abstract][Full Text] [Related]
39. The Difference in the Clinical Features Between Carcinoma ex Pleomorphic Adenoma and Pleomorphic Adenoma.
Seok J; Hyun SJ; Jeong WJ; Ahn SH; Kim H; Jung YH
Ear Nose Throat J; 2019 Sep; 98(8):504-509. PubMed ID: 31189352
[TBL] [Abstract][Full Text] [Related]
40. Influence of p16 Protein Immunostaining on Histopathological Features of Pleomorphic Adenoma and Carcinoma ex- Pleomorphic Adenoma.
Magalhaes IA; Barbosa KC; Costa GAJ; Oliveira Filho OV; Da Silva Junior JE; Gonzaga Silva LF; Juaçaba SF; Sousa FB; Barros Silva PG
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3815-3824. PubMed ID: 38019239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
